• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人附睾蛋白 4(HE4)在卵巢癌细胞黏附和迁移中发挥关键作用。

Human epididymis protein 4 (HE4) plays a key role in ovarian cancer cell adhesion and motility.

机构信息

Department of Clinical Laboratory, Fudan University, Shanghai Cancer Center, Shanghai 200032, China.

出版信息

Biochem Biophys Res Commun. 2012 Mar 9;419(2):274-80. doi: 10.1016/j.bbrc.2012.02.008. Epub 2012 Feb 10.

DOI:10.1016/j.bbrc.2012.02.008
PMID:22342977
Abstract

Human epididymis protein 4 (HE4) is a novel and specific biomarker for epithelial ovarian cancer (EOC). We previously demonstrated that serum HE4 levels were significantly elevated in the majority of EOC patients but not in subjects with benign disease or healthy controls. However, the precise mechanism of HE4 protein function is unknown. In this study, we generated HE4-overexpressing SKOV3 cells and found that stably transduced cells promoted cell adhesion and migration. Knockdown of HE4 expression was achieved by stable transfection of SKOV3 cells with a construct encoding a short hairpin DNA directed against the HE4 gene. Correspondingly, the proliferation and spreading ability of HE4-expressed cells were inhibited by HE4 suppression. Mechanistically, impaired EGFR and Erk1/2 phosphorylation were observed in cells with HE4 knockdown. The phosphorylation was restored when the knockdown cells were cultured in conditioned medium containing HE4. Moreover, in vivo tumorigenicity showed that HE4 suppression markedly inhibited the growth of tumors. This suggests that expression of HE4 is associated with cancer cell adhesion, migration and tumor growth, which can be related to its effects on the EGFR-MAPK signaling pathway. Our results provide evidence of the cellular and molecular mechanisms that may underlie the motility-promoting role of HE4 in EOC progression. The role of HE4 as a target for gene-based therapy might be considered in future studies.

摘要

人附睾蛋白 4(HE4)是一种新型的上皮性卵巢癌(EOC)特异性标志物。我们之前的研究表明,在大多数 EOC 患者中,血清 HE4 水平显著升高,但在良性疾病或健康对照者中则不升高。然而,HE4 蛋白功能的确切机制尚不清楚。在本研究中,我们生成了 HE4 过表达 SKOV3 细胞,发现稳定转染的细胞促进了细胞黏附和迁移。通过用针对 HE4 基因的短发夹 DNA 构建体稳定转染 SKOV3 细胞,实现了 HE4 表达的下调。相应地,下调 HE4 表达抑制了 HE4 表达细胞的增殖和扩展能力。在机制上,观察到 HE4 下调的细胞中 EGFR 和 Erk1/2 磷酸化受损。当将敲低细胞在含有 HE4 的条件培养基中培养时,磷酸化得到恢复。此外,体内肿瘤发生表明,下调 HE4 明显抑制了肿瘤的生长。这表明 HE4 的表达与癌细胞黏附、迁移和肿瘤生长有关,这可能与其对 EGFR-MAPK 信号通路的影响有关。我们的研究结果为 HE4 在 EOC 进展中促进运动的作用的细胞和分子机制提供了证据。在未来的研究中,可以考虑将 HE4 作为基因治疗的靶标。

相似文献

1
Human epididymis protein 4 (HE4) plays a key role in ovarian cancer cell adhesion and motility.人附睾蛋白 4(HE4)在卵巢癌细胞黏附和迁移中发挥关键作用。
Biochem Biophys Res Commun. 2012 Mar 9;419(2):274-80. doi: 10.1016/j.bbrc.2012.02.008. Epub 2012 Feb 10.
2
Human epididymis protein 4 inhibits proliferation of human ovarian cancer cells via the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways.人附睾蛋白4通过丝裂原活化蛋白激酶和磷酸肌醇3激酶/蛋白激酶B信号通路抑制人卵巢癌细胞的增殖。
Int J Gynecol Cancer. 2014 Mar;24(3):427-36. doi: 10.1097/IGC.0000000000000078.
3
Role of human epididymis protein 4 in chemoresistance and prognosis of epithelial ovarian cancer.人附睾蛋白4在上皮性卵巢癌化疗耐药及预后中的作用
J Obstet Gynaecol Res. 2017 Jan;43(1):220-227. doi: 10.1111/jog.13181. Epub 2016 Nov 12.
4
Promotive role of recombinant HE4 protein in proliferation and carboplatin resistance in ovarian cancer cells.重组人附睾蛋白4(HE4)蛋白对卵巢癌细胞增殖及顺铂耐药性的促进作用
Oncol Rep. 2015 Jan;33(1):403-12. doi: 10.3892/or.2014.3549. Epub 2014 Oct 17.
5
HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells.人附睾蛋白4促进卵巢癌细胞对顺铂和紫杉醇的侧支抗性。
J Ovarian Res. 2016 May 17;9(1):28. doi: 10.1186/s13048-016-0240-0.
6
[Effect of down-regulation of HE4 gene expression on biologic behavior of ovarian cancer cells].[下调HE4基因表达对卵巢癌细胞生物学行为的影响]
Zhonghua Bing Li Xue Za Zhi. 2013 Oct;42(10):687-90.
7
Upregulated CTHRC1 promotes human epithelial ovarian cancer invasion through activating EGFR signaling.CTHRC1表达上调通过激活表皮生长因子受体(EGFR)信号通路促进人上皮性卵巢癌的侵袭。
Oncol Rep. 2016 Dec;36(6):3588-3596. doi: 10.3892/or.2016.5198. Epub 2016 Oct 24.
8
Does Human Epididymis Protein 4 (HE4) Have a Role in Prediction of Recurrent Epithelial Ovarian Cancer.人附睾蛋白4(HE4)在复发性上皮性卵巢癌的预测中起作用吗?
Asian Pac J Cancer Prev. 2016;17(9):4483-4486.
9
MUC20 promotes aggressive phenotypes of epithelial ovarian cancer cells via activation of the integrin β1 pathway.MUC20 通过激活整合素 β1 通路促进上皮性卵巢癌细胞的侵袭表型。
Gynecol Oncol. 2016 Jan;140(1):131-7. doi: 10.1016/j.ygyno.2015.11.025. Epub 2015 Nov 23.
10
Analysis of the gene expression profile in response to human epididymis protein 4 in epithelial ovarian cancer cells.上皮性卵巢癌细胞中响应人附睾蛋白4的基因表达谱分析。
Oncol Rep. 2016 Sep;36(3):1592-604. doi: 10.3892/or.2016.4926. Epub 2016 Jul 11.

引用本文的文献

1
Human epididymis protein 4-annexin II binding promotes aberrant epithelial-fibroblast crosstalk in pulmonary fibrosis.人附睾蛋白4与膜联蛋白II结合促进肺纤维化中异常的上皮-成纤维细胞相互作用。
Commun Biol. 2025 Jan 20;8(1):93. doi: 10.1038/s42003-025-07529-7.
2
Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis.HE4 在卵巢癌发生中的作用的最新见解。
Int J Mol Sci. 2023 Jun 22;24(13):10479. doi: 10.3390/ijms241310479.
3
Prognostic Significance of HE4 Tissue Expression in Serous Epithelial Ovarian Carcinoma.HE4组织表达在浆液性上皮性卵巢癌中的预后意义
South Asian J Cancer. 2022 Feb 27;11(2):125-132. doi: 10.1055/s-0042-1742711. eCollection 2022 Apr.
4
HE4 Tissue Expression as A Putative Prognostic Marker in Low-Risk/Low-Grade Endometrioid Endometrial Cancer: A Review.HE4 组织表达作为低风险/低级别子宫内膜样子宫内膜癌的潜在预后标志物:综述。
Curr Oncol. 2022 Nov 10;29(11):8540-8555. doi: 10.3390/curroncol29110673.
5
Menstrual Fluid Factors Mediate Endometrial Repair.月经液因子介导子宫内膜修复。
Front Reprod Health. 2021 Dec 21;3:779979. doi: 10.3389/frph.2021.779979. eCollection 2021.
6
Biomarker-Based Models for Preoperative Assessment of Adnexal Mass: A Multicenter Validation Study.基于生物标志物的附件包块术前评估模型:一项多中心验证研究
Cancers (Basel). 2022 Mar 31;14(7):1780. doi: 10.3390/cancers14071780.
7
Current clinical application of serum biomarkers to detect and monitor ovarian cancer - update.血清生物标志物在卵巢癌检测和监测中的当前临床应用——最新进展
Prz Menopauzalny. 2021 Dec;20(4):211-216. doi: 10.5114/pm.2021.112474. Epub 2022 Jan 6.
8
BC-DETECT: combined detection of serum HE4 and TFF3 improves breast cancer diagnostic efficacy.BC-DETECT:联合检测血清人附睾蛋白4(HE4)和三叶因子3(TFF3)可提高乳腺癌诊断效能。
Breast Cancer. 2022 May;29(3):507-515. doi: 10.1007/s12282-021-01328-8. Epub 2022 Jan 7.
9
WFDC Protein: A Promising Diagnosis Biomarker of Ovarian Cancer.WFDC蛋白:一种有前景的卵巢癌诊断生物标志物。
J Cancer. 2021 Jul 6;12(18):5404-5412. doi: 10.7150/jca.57880. eCollection 2021.
10
, A New Potential Tumor Marker for Early Diagnosis and Predicting of Breast Cancer Progression.一种用于乳腺癌早期诊断和进展预测的新潜在肿瘤标志物。
Iran J Pathol. 2021 Summer;16(3):284-296. doi: 10.30699/IJP.2021.135323.2482. Epub 2021 Jun 12.